Funding

Open calls for research funding, each checked against its official source.

Funding opportunities

64

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Funder: National Institutes of Health · Opportunity type: Grant

Supports investigator-led clinical trials intended to reduce the burden of cancer through prevention, screening, healthcare delivery, supportive care or survivorship. Trials of cancer diagnosis or cancer-directed treatme...

Opens
2025-01-05
Deadline
2026-10-05
Call status
Closed
Last checked
2026-09-19

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Funder: National Institutes of Health · Opportunity type: Research funding opportunity

Supports planning and feasibility research for cancer prevention and control clinical trials. Projects should resolve practical or scientific uncertainties needed to finalise a future trial, with an optional pilot clinic...

Opens
2025-01-25
Deadline
2026-10-26
Funding amount
Up to USD 450000 in direct costs over 3 years, or USD 600000 with a pilot trial; maximum USD 225000 per year
Call status
Closing soon
Last checked
2026-09-19

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Funder: National Institutes of Health · Opportunity type: Research funding opportunity

Supports preparation of cancer prevention and control clinical trials, including feasibility studies that resolve uncertainties about recruitment, interventions, outcomes, study design or operations. An optional pilot tr...

Opens
2025-01-25
Deadline
2026-10-26
Funding amount
Up to USD 450000 in direct costs over 3 years, or USD 600000 with a pilot trial; maximum USD 225000 per year
Call status
Closing soon
Last checked
2026-09-19

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Funder: National Institutes of Health · Opportunity type: Research funding opportunity

Supports collaborative studies of persistent or delayed adverse effects of cancer treatment. Research may identify underlying mechanisms, characterise long-term clinical effects or develop approaches to prevent or reduce...

Opens
2025-01-05
Deadline
2026-10-05
Call status
Closed
Last checked
2026-09-19

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Funder: National Institutes of Health · Opportunity type: Grant

Supports high-risk, potentially transformative basic research on substance use disorders. Projects should test unconventional hypotheses or develop substantially new techniques where supporting evidence is limited and po...

Opens
2025-02-10
Deadline
2027-03-10
Funding amount
Up to USD 275000 in direct costs over 2 years; maximum USD 150000 per year
Call status
Open
Last checked
2026-09-19

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Funder: National Institutes of Health · Opportunity type: Grant

Supports new theories and analytical methods explaining how genetic and non-genetic factors shape complex human traits. Interdisciplinary projects should combine modelling with validation using large existing datasets.

Opens
2025-01-05
Deadline
2026-10-05
Funding amount
NCI applications: up to USD 350000 in direct costs per year; other participating institutes set no fixed cap
Call status
Closed
Last checked
2026-09-19

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Funder: National Institutes of Health · Opportunity type: Grant

Supports exploratory development of theories and methods explaining the genetic and non-genetic influences on complex human traits. Projects should integrate perspectives across disciplines and test ideas through simulat...

Opens
2025-01-16
Deadline
2026-10-16
Funding amount
Up to USD 275000 in direct costs over 2 years; maximum USD 200000 per year
Call status
Closed
Last checked
2026-09-19